UNSPSC 51152004: Vecuronium

This classification denotes a nicotinic antagonist with the molecular formula C34H57N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5438723848, chemically known as 5alpha-androstan-3alpha,17beta-diol, 16beta-pipecolinio-2beta-piperidino-,bromide,diacetate but generally known as vecuronium, which bears US NIH Compound Identifier 39764. European Medicines Agency schedules Vecuronium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05084MIG.

UNSPSC 51152004 Vecuronium is a Commodity code that covers pharmaceutical products, though recent state and local solicitations under this code show activity in emergency response supplies rather than the anesthetic agent the code nominally describes. Seminole County, Florida's recent procurement demonstrates that governments use this code to source naloxone and drug deactivation systems for community health and emergency preparedness initiatives. The issuing body in the recent opportunity record is a county health department or public health authority managing inventory for quarterly distribution to community health facilities.

Seminole County's IFB 60459723LAS, posted June 30, 2026 with a response deadline of July 26, 2023, sought 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding. The county required electronic bid submission through its e-Procurement Portal, with vendors responsible for all shipping and delivery costs to the Seminole County Community Health Building in Sanford, Florida. The contract offered a two-year initial term with a one-year renewal option and included standard compliance requirements such as drug-free workplace certification, E-Verify, workers' compensation, and commercial general liability insurance. FEMA funding was identified as a potential source, which introduced federal compliance obligations including the Clean Air Act and Federal Water Pollution Control Act. The code shows limited recent activity; this single opportunity is the only recent state or local solicitation identified under it, and the mismatch between the code's pharmaceutical scope and the naloxone/deactivation-systems procurement suggests either a tagging error or that this code is rarely used for state and local purchasing.